Immunologic defenses against cancer.
D000818:Animals; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D002464:Cell Migration Inhibition; D002648:Child; D003429:Cross Reactions; D005455:Fluorescent Antibody Technique; D006649:Histocompatibility Antigens; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007167:Immunotherapy; D007223:Infant; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D009365:Neoplasm Regression, Spontaneous; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D006649:Histocompatibility Antigens